Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Introduction to Tazowel 4.5 Injection
Tazowel 4.5 Injection is a trusted combination therapy for managing severe bacterial infections. With Piperacillin 4g and Tazobactam 0.5g, this broad-spectrum formulation offers enhanced antibacterial activity and reliable protection against resistant strains.
Uses of Tazowel 4.5 Injection
Treatment of hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP)
Management of complicated intra-abdominal infections (e.g., peritonitis)
Effective for complicated urinary tract infections (UTIs), including pyelonephritis
Useful in treating complicated skin and soft tissue infections
Helps manage severe bloodstream infections (sepsis) and other serious bacterial infections
Benefits of Tazowel 4.5 Injection
Broad-spectrum activity against a wide range of bacterial pathogens
Effective against beta-lactamase-producing bacteria
Reliable treatment for severe and life-threatening infections
Clinically proven efficacy in critical care and hospital settings
Rapid bacterial clearance, promoting faster recovery
Mechanism of Action of Tazowel 4.5 Injection
Piperacillin kills bacteria by inhibiting cell wall synthesis, leading to cell lysis.
Tazobactam blocks beta-lactamase enzymes, ensuring Piperacillin remains effective against resistant bacteria.
Together, they provide comprehensive infection control, even in challenging infections.
For best results, use Tazowel 4.5 Injection as directed by your healthcare provider. Follow the recommended dosage and duration of therapy to ensure complete bacterial eradication. Store and handle according to guidelines and keep out of reach of children.